Surfact 108 Solution

Colfosceril palmitate
Sun Pharmaceutical Industries Ltd.
Pack size
Dispensing mode
Source
Agent
Retail Price

Indications

Surfact 108 Solution is used for: Neonatal respiratory distress syndrome

Adult Dose

Child Dose

Endotracheal Neonatal respiratory distress syndrome Child: In neonates: 67.5 mg/kg. Given as a suspension by endotracheal tube directly into the infant's lung.

Renal Dose

Administration

Contra Indications

Precautions

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Colfosceril palmitate :

Mechanism of Action

Colfosceril palmitate is a phospholipid. It forms an important constituent of natural and many synthetic pulmonary surfactant compounds.

Note

Surfact 108 Solution manufactured by Sun Pharmaceutical Industries Ltd.. Its generic name is Colfosceril palmitate. Surfact 108 is availble in Nepal. Farmaco Nepal drug index information on Surfact 108 Solution is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Colfosceril palmitate :